Violacean phytomedicines for periodontal disease management

Technology
Conceptual
University

This solution involves the development of phytomedicines derived from Viola herb actives to manage periodontal disease. The project focuses on isolating bioactive compounds, understanding their antimicrobial and anti-inflammatory properties, and creating a standardized herbal preparation for oral care products.

Overview

Violacean phytomedicines represent a novel approach to managing periodontal disease through the use of bioactive compounds found in Viola herbs. These compounds exhibit antimicrobial and anti-inflammatory properties, making them suitable for oral care applications such as toothpaste or mouthwash. The goal is to develop a standardized herbal preparation that can be commercialized as an effective oral health product.

Technical specifications
  • Phytochemical Analysis: Involves isolating and characterizing active compounds from Viola herb extracts.
  • Bioactivity Profiling: Evaluates antimicrobial activity against oral pathogens and safety in cell-based assays.
  • Mechanistic Insights: Studies the impact of these compounds on gingival fibroblasts and their interaction with immune cells.
  • Prototype Development: Aims to create an optimized herbal preparation ready for commercialization.
Technology readiness level

Currently at TRL 3, the technology involves active research and development phases, with laboratory validation underway. Future work includes preclinical safety assessments and proof-of-concept studies in periodontitis models.


About University of Vienna

The University of Vienna is Austria’s largest public research university, with about 85,000 students and 11,000 staff, and a broad, internationally connected research profile. Its urban location places corporate R&D teams within Vienna’s dense academic, medical, technology and startup ecosystem. Joint platforms with the Medical University of Vienna, including the Max Perutz Labs at the Vienna BioCenter, support shared infrastructure and cross-institutional collaboration. Research services support competitive funding from the Austrian Science Fund, Austrian Research Promotion Agency, Vienna Science and Technology Fund and EU programmes. A dedicated technology-transfer function helps companies identify partners and technologies while supporting cooperation agreements, IP protection, licensing, spin-offs and startups.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.